Clinical TrialID 6629
Cantharone for the Treatment of Perenial Warts
NCT03625960
Wart, Genital
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6629
- Evidence Id
- 6629
- Core Evidence Id
- 6629
- Source Clinical Trial Id
- 6616
- Herb2 Clinical Trial Id
- HBCT006616
- Nct Id
- NCT03625960
- Title
- Cantharone for the Treatment of Perenial Warts
- Status
- Completed
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Wart, Genital
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Cantharidin|DRUG: Trichloroacetic Acid
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- Female
- Age
- Adult, Older_Adult
- Enrollment
- 12
- Outcome Measure
- Pain on treatment, Comparison of pain when treatment is applied. The patient is asked on a scale of 0-5 (with 5 being extreme pain, 4 being severe pain, 3 being moderate, 2 being mild, 1 being slight and zero being no pain, how do you rate your pain., at 30 minutes time point from application of treatment.
- Sponsor Collaborator
- Wayne State University|University of California, San Francisco|St Vincent's Hospital
- Funded By
- OTHER
- Location
- Other Id
- 1551
- Start Date
- 2006-06-15
- Primary Completion Date
- 2007-06-15
- Completion Date
- 2007-07-15
- First Posted
- 2018-08-10
- Results First Posted
- Last Update Posted
- 2018-08-10
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03625960
- Title Cn
- Title En
- Cantharone for the Treatment of Perenial Warts
- Bilingual Status
- semi_complete